Epstein Secrets

Chief Medical Officer Merdad Parsey EFTA00135821 said the drug has approvals or authorizations in around 50 countries. The New Ynrk TIMP4 (10/22, Levenson, 18.61M) reports the FDA's announcement "indicated that the drug had cleared more rigorous regulatory hurdles involving a more thorough review of c

y rights, and a wide range of other policy issues including health care access, gun safety and religious freedom." The Washington Post (10/22, Kim, Firozi, Cassata, 14.2M) reports Barrett "repeatedly declined to offer her legal views on presidential authority and voter intimidation" during her confirm

approvals or authorizations in around 50 countries. The New York Times <https://www.nytimes.com/2020/10/22/us/remdesivir-fda-approved.html> (10/22, Levenson, 18.61M) reports the FDA's announcement "indicated that the drug had cleared more rigorous regulatory hurdles involving a more thorough review of cl

ous freedom." The Washington Post <https://www.washingtonpost.corn/politics/2020/10/22/amy-coney-barrett-nomination- vote-live-updatesk (10/22, Kim, Firozi, Cassata, I4.2M) reports Barrett "repeatedly declined to offer her legal views on presidential authority and voter intimidation" during her confirma

ez." Miller also posted: "They are right next time we bring the guns," an FBI agent wrote in an affidavit. EFTA00148169 The New York Times (1/23, Levenson, 20.6M) reports, "Surveillance video from inside the Capitol, a selfie and a video posted by Mr. Miller and comments he made on social media showed

nation, so yes, I think that the supply is probably going to be the most limiting constraint early on." The Washington Post (1/24, Goldstein, Wang, Firozi, Knowles, 10.52M) covers Walensky's remarks and reports that "as officials push to ramp up inoculation efforts to help crush the pandemic, increasi

Chief Medical Officer Merdad Parsey said the drug has approvals or authorizations in around 50 countries. EFTA00148471 The New York Times (10/22, Levenson, 18.61M) reports the FDA's announcement "indicated that the drug had cleared more rigorous regulatory hurdles involving a more thorough review of c

y rights, and a wide range of other policy issues including health care access, gun safety and religious freedom." The Washington Post (10/22, Kim, Firozi, Cassata, 14.2M) reports Barrett "repeatedly declined to offer her legal views on presidential authority and voter intimidation" during her confirm